| Role |
Name |
Disclosure |
Details |
| Author | Thwe T Htay, MD, Assistant Professor, Department of Medicine, University of Texas Health Science Center at San Antonio | Nothing to disclose | Details | | Coauthor | KoKo Aung, MD, MPH, FACP, Assistant Professor, Department of Medicine, University of Texas Health Science Center; Adjunct Assistant Professor of Public Health, University of Texas School of Public Health | Nothing to disclose | Details | | Coauthor | John Carrick, MD, Consulting Staff, Department of Psychiatry, Flagstaff Medical Center | Nothing to disclose | Details | | Coauthor | Romeo Papica II, MD, Research Associate, Department of Internal Medicine, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Medical Editor | Ronald C Albucher, MD, Chief Medical Officer, Westside Community Services; Consulting Staff, California Pacific Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Iqbal Ahmed, MBBS, Professor, Department of Psychiatry, John A Burns School of Medicine, University of Hawaii | Nothing to disclose | Details | | CME Editor | Harold H Harsch, MD, Program Director of Geropsychiatry, Department of Geriatrics/Gerontology, Associate Professor, Department of Psychiatry and Department of Medicine, Froedtert Hospital, Medical College of Wisconsin | lilly BMS Forest Labs AstraZeneca Pfizer Northstar Novartis Pfizer | Details | | Chief Editor | Stephen Soreff, MD, President of Education Initiatives, Nottingham, NH; Faculty, Metropolitan College of Boston University, Boston, MA | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| John Carrick, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Romeo Papica II, Coauthor |
The contributor discloses no conflict of interest. |
|